兴和制药（中国）有限公司于2013年7月9日正式注册成立，注册资本3000万美金，投资总额9000万美金，兴和制药（中国）肩负研发和生产，业务涉及处方药、OTC产品以及日用百货等。兴和制药（中国）的成立为中国业务的发展和成长提供了更多机遇，成为每个兴和员工施展才华的广阔平台。我们秉承充分整合、利用市场的优良资源，加强管理，全力呵护和改善服务品质；努力发挥聪明才智，同心同德，不辱使命，共同创造和分享美好明天！KowaPharmaceuticals(China)Co.LtdwasformallyregisteredonJuly9,2013,registeredcapitalofUSD$30million,totalinvestmentuptoUSD$90million,aimingatresearchanddevelopmentandproduction,businessinvolvesRX,OTCproductsandgeneralmerchandise,etc.TheestablishmentofKPCprovidesmoreopportunitiesforthedevelopmentandgrowthofbusinessinChina,alsobuildabroaderplatformforeveryemployeetodisplaytheirtalent.Integratingandutilizatingofgoodresources,reinforcingofthemanagementandimprovingthequalityoftheservicearethephilosophyofKPC.Letusworktogethertocreateabettertomorrow!